Search results
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 3 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
Stock market today: Wall Street coasts to the finish line of another winning week
Associated Press Finance via Yahoo Finance· 1 day agoThe S&P 500 has climbed back within 0.6% of its record on revived hopes that the Federal Reserve may...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
WFRV 5 Green Bay· 1 day agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19
Dogness Announces Entry into US$5.0 Million Private Placement
KTBS Shreveport· 2 days agoDogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, ...
How is CT keeping milk safe from bird flu— and preparing for a potential human pandemic?
Stamford Advocate· 3 hours agoConnecticut officials say they will be much more prepared than they were for COVID-19 if a deadly...
Will These 5 Medical Device Stocks Beat This Earnings Season?
Zacks via Yahoo Finance· 5 days agoMedical Device companies' quarterly results are likely to reflect strength in customer demand. Let's...
MPR News Podcasts
MPR News· 19 hours agoCheck out MPR News podcasts, the latest from Minnesota Today to in-depth conversations on news and culture with Angela Davis and stories from around Minnesota with Cathy Wurzer.
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home...
Digital Journal· 2 days ago...available market for the company's products will not be as large as expected, the company's products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company's cash needs, fund further development, as well as uncertainties relative to the ...
BioLargo Q1 2024 Earnings Results Webcast and Conference Call on Tuesday, May 14, 2024
Digital Journal· 1 day agoThese forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding the impact of the COVID-19 pandemic ...
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Digital Journal· 1 day ago...of potential approval from New York State Department of Health for our pharmacogenetic testing services, limited market acceptance for its supply chain security products and services, the declining demand for Applied DNA's COVID-19 testing services, the fact that there has never been a commercial...
